Colgate-Palmolive (India) Ltd (COLPAL) Q1 FY27 Results Analysis: Revenue Grows 12%, Margin Compresses 150 bps
Colgate-Palmolive (India) Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 1,590.56 Cr (+11.96% YoY) and PAT growth of +7.01% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | July 29, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Revenue (Q1) | Rs. 1,590.56 Cr (+11.96% YoY) |
| PAT (Q1) | Rs. 343.08 Cr (+7.01% YoY) |
| EBITDA margin | 30.36% (-150 bps YoY) |
| EPS (Q1) | Rs. 12.61 (+6.96% YoY) |
| Market cap | Rs. 58,914.83 Cr |
| CMP | Rs. 2,166.05 |
Quarter Snapshot
Revenue grew 12% YoY, the fastest in two years, driven by high-single digit volume growth and premium toothpaste. However, EBITDA margin compressed 150 bps YoY due to a sharp advertising step-up (33.7% YoY) and raw material cost inflation (up 25% YoY). PAT growth lagged at 7%. The company is investing for growth, but near-term margin headwinds are significant.
Key Investment Insights
Key Positives
- Net sales grew 11.96% YoY to Rs.1,590.56 Cr, the fastest quarterly growth in at least two years.
- High-single digit volume growth in toothpaste portfolio, driven by premium segment.
- Gross margin at 69.73% came in slightly above the guided range of 69.3-69.6%.
- Management confirmed volume-driven growth priority and stepped up advertising to support premiumization.
Risk Factors
- EBITDA margin compressed 150 bps YoY to 30.36% and 184 bps QoQ.
- Advertising spend jumped 33.68% YoY to Rs.251.86 Cr, representing 15.83% of net sales, pressuring margins.
- Cost of materials consumed surged 25.18% YoY due to commodity inflation and rupee depreciation.
- PAT growth of 7.01% YoY lagged revenue growth of 11.96%, reflecting margin compression.
- Exceptional items of Rs.3.34 Cr for GST inverted duty structure and restructuring costs.
- Forex headwind from rupee depreciation (~2.1% QoQ) impacted material costs.
Ask about this
Ask Cofacto a question about this result. Answers cite filings and company data.
Related
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.